Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Arkansas

Phase 1 cancer trials in Arkansas

12 Phase 1 cancer studies are recruiting participants at sites in 5 cities across Arkansas as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Arkansas city with a recruiting study

By research area: Breast Cancer (4), Lung Cancer (3), Lymphoma (2), Prostate Cancer (2), Pancreatic Cancer (1).

Little Rock (6), Fayetteville (4), Springdale (3), Rogers (2), Hot Springs (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Arkansas

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Stemline Therapeutics, Inc.
    Recruiting in
    Springdale
    Registry record
    NCT06638307 · updated
  2. A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

    • Phase 1
    • Ages 18 to 55
    • Female participants
    Sponsor
    TerSera Therapeutics LLC
    Recruiting in
    Hot Springs
    Registry record
    NCT07310420 · updated
  3. A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 19 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Recruiting in
    Little Rock
    Registry record
    NCT06586957 · updated
  4. A Study of Sigvotatug Vedotin in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Recruiting in
    Fayetteville · Rogers · Springdale
    Registry record
    NCT04389632 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Arkansas on ClinicalTrials.gov.

Lung cancer: recently updated in Arkansas

  1. A Study of DS-3939a in Participants With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Daiichi Sankyo
    Recruiting in
    Fayetteville
    Registry record
    NCT07739966 · updated
  2. Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Fayetteville · Rogers · Springdale
    Registry record
    NCT07227298 · updated
  3. Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Whitehawk Therapeutics, Inc.
    Recruiting in
    Little Rock
    Registry record
    NCT07444814 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Arkansas on ClinicalTrials.gov.

Prostate cancer: recently updated in Arkansas

  1. Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

    • Phase 1/2
    • Ages 18 to 130
    • Male participants
    Sponsor
    AstraZeneca
    Recruiting in
    Fayetteville
    Registry record
    NCT07181161 · updated
  2. A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy

    • Phase 1
    • Ages 18 to 100
    • Male participants
    Sponsor
    University of Arkansas
    Recruiting in
    Little Rock
    Registry record
    NCT06044025 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Arkansas on ClinicalTrials.gov.

Lymphoma: recently updated in Arkansas

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Recruiting in
    Little Rock
    Registry record
    NCT04726241 · updated
  2. TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

    • Phase 1/2
    • Up to age 1
    • All sexes
    Sponsor
    Tanja Andrea Gruber
    Recruiting in
    Little Rock
    Registry record
    NCT05848687 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Arkansas on ClinicalTrials.gov.

Pancreatic cancer: recently updated in Arkansas

  1. Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Arkansas
    Recruiting in
    Little Rock
    Registry record
    NCT07539155 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Arkansas on ClinicalTrials.gov.

Ask about studies in Arkansas

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call